COVID-19 vaccine hesitancy in systemic sclerosis
Abstract
In conclusion, our survey suggests that most patients with SSc have positive feelings towards COVID-19 vaccine, but uncertainties are present in a considerable proportion of cases.
These results highlight the crucial role of the caring rheumatologists in addressing concerns and hesitancy of individuals affected by rheumatic diseases with the purpose of promoting vaccine literacy and enhancing vaccination rates.
Citations
J. Ciaffi, D. Giuggioli, A. Mari, M. D'onghia, A. Spinella, V. Brusi, L. Mancarella, L. Lisi, J. Faranda Cordella, D. Freeman, M.P. Landini, C. Ferri, R. Meliconi F. Ursini. COVID-19 vaccine hesitancy in systemic sclerosis. Exp Rheumatol . Jul-Aug 2021;39 Suppl 131(4):165-166. Epub 2021 Jul 15.
Sponsorship: Supported by the NIHR
DOI: https://www.clinexprheumatol.org/abstract.asp?a=17374
URI: https://www.oxfordhealth.nhs.uk/orka/title/covid-19-vaccine-hesitancy-in-systemic-sclerosis/
Page last reviewed: 12 June, 2025
Metadata
Author(s): Freeman, Daniel
Collection: 123456789/29
Subject(s): COVID-19, Sclerosis, Vaccine Hesitancy
Format(s): Article
Date issued: 2021-07
ID: 901